¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hereditary bone dysplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • fibrous dysplasia polyostotic
    ¿©·¯»À¼¶À¯Çü¼ºÀÌ»ó, ´Ù°ñ¼¶À¯ÀÌÇü¼º
  • hypohidrotic ectodermal dysplasia
    ¶¡ÀúÇϿܹ迱Çü¼ºÀÌ»óÁõ, ¹ßÇÑÀúÇϼº¿Ü¹è¿±Çü¼ºÀÌ»óÁõ
  • hidrotic ectodermal dysplasia
    ¶¡È긲¿Ü¹è¿±Çü¼ºÀÌ»óÁõ, ¹ßÇѼº¿Ü¹è¿±Çü¼ºÀÌ»óÁõ
  • multiple epiphyseal dysplasia
    ¹µ»À³¡Çü¼ºÀÌ»ó, ´Ù¹ß°ñ´ÜÇü¼ºÀÌ»ó
  • mammary dysplasia
    À¯¹æÇü¼ºÀÌ»ó
  • metaphyseal dysplasia
    »À¸öÅ볡Çü¼ºÀÌ»ó, °ñ°£´ÜÇü¼ºÀÌ»ó
  • oculoauriculovertebral dysplasia
    ´«±ÍôÃßÇü¼ºÀÌ»ó, ¾ÈÀÌôÃßÇü¼ºÀÌ»ó
  • oculodentodigital dysplasia
    ´«Ä¡¾Æ°¡¶ôÇü¼ºÀÌ»ó, ¾ÈÄ¡¾ÆÁöÇü¼ºÀÌ»óÁõ
  • progressive diaphyseal dysplasia
    ÁøÇ༺»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇ༺°ñ°£Çü¼ºÀÌ»ó
  • spondyloepiphyseal dysplasia
    ôÃßÆÈ´Ù¸®»À³¡Çü¼ºÀÌ»ó, ôÃß°ñ´ÜÇü¼ºÀÌ»ó
  • aneurysmal bone cyst
    µ¿¸Æ·ù»À³¶Á¾
  • autogenous bone graft
    ÀÚ°¡»ÀÀ̽Ä, ÀÚ°¡°ñÀ̽Ä
  • air-bone gap
    °ø±â»ÀÀüµµÂ÷ÀÌ
  • alveolar bone
    ÀÌÆ²»À, Ä¡Á¶°ñ
  • alveolar bone graft
    ÀÌÆ²»ÀÀ̽Ä, Ä¡Á¶°ñÀ̽Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary spherocytosis
    À¯ÀüµÕ±ÙÀûÇ÷±¸Áõ, À¯Àü±¸ÇüÀûÇ÷±¸Áõ
  • hereditary stigma
    À¯Àü¡ǥ
  • hereditary syphilis
    (¢¡congenital syphilis) ¼±Ãµ¸Åµ¶
  • hereditary trait
    À¯Àü¼ÒÁú
  • hereditary tremor
    (¢¡essential tremor) º»Å¶³¸², À¯Àü¶³¸², ¿øÀθ𸦶³¸²
  • hereditary adrenogenital syndrome
    À¯ÀüºÎ½Å¼º±âÁõÈıº
  • hereditary hemorrhagic telangiectasia
    À¯ÀüÃâÇ÷¸ð¼¼Ç÷°üÈ®ÀåÁõ, À¯ÀüÃâÇ÷½ÇÇÍÁÙÈ®ÀåÁõ
  • hereditary motor sensory neuropathy
    À¯Àü¿îµ¿°¨°¢½Å°æº´Áõ
  • hereditary mutilating keratoma
    À¯ÀüÀý´Ü°¢È­Á¾
  • hereditary palmoplantar keratoderma
    À¯Àü¼Õ¹ß¹Ù´Ú°¢ÁúÇǺÎÁõ
  • hereditary pyloric stenosis
    À¯Àü³¯¹®ÇùÂø
  • hereditary spastic paraplegia
    À¯Àü°æÁ÷ÇϹݽŸ¶ºñ
  • hereditary tubulointerstitial nephritis
    À¯Àü´¢¼¼°ü»çÀÌÁúÄáÆÏ¿°
  • air-bone gap
    °ø±â»ÀÀüµµÂ÷ÀÌ
  • alveolar bone
    ÀÌÆ²»À
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hamulus of hamate bone
    °¥°í¸®»À°¥°í¸®
  • haunch bone =hip b. innominate
    Á°ñ(µÐ ¿äºÎ)(¡­Ôëé¦Ý»).
  • head of metatarsal bone
    ¹ßÇ㸮»À¸Ó¸®
  • hearing, bone conduction
    °ñµµÃ»·Â
  • heel bone =calcaneus
    Á¾°ñ(ñ¢Íé).
  • heel bone =calcaneus
    Á¾°ñ(ñ¢Íé)£¬µÚ²ÞÄ¡ »À.
  • herring bone appearance
    û¾î»À ¸ð¾ç
  • hip bone
    °ü°ñ(ΰÍé).
  • hip bone
    º¼±â»À °ü°ñ
  • hip bone
    °ü°ñ(ΰÍé), µÐ°ñ(ÔëÍé), °í°ñ(ÍÆÍé), °ñ¹Ý°ñ(ÍéÚïÍé), ¹«¸í°ñ(ÙíÙ£Íé), ¾ûÄ¡»À.
  • horn of hyoid bone
    ¼³°ñ»Ô, »ó°¢(ß¾ÊÇ).
  • hyoid bone
    ¼³°ñ.
  • hyoid bone
    ¸ñ»Ô»À ¼³°ñ
  • hyoid bone
    ¼³°ñ
  • iliac bone <³ª> os ilium
    Àå°ñ(Àå°ñ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mammary dysplasia
    À¯¹æÀÌÇü¼º(¡­ì¶û¡à÷)
  • mammary dysplasia
    À¯¹æÀÌÇü¼º(¡­ì¶û¡à÷).
  • mammary dysplasia
    À¯¹æÀÌÇü¼º(¡­ì¶û¡à÷)
  • metaphysial dysplasia
  • monostotic fibrous dysplasia
    ¹æ»ç ´Ü°ñ¼¶À¯¼º ÀÌÇü¼ºÁõ.
  • monostotic fibrous dysplasia
    ´Ü°ñ¼¶À¯¼º ÀÌÇü¼ºÁõ(Û¯ÞÒ Ó¤Íéàéë«àõ ì¶û¡à÷ñø)
  • monostotic fibrous dysplasia
    ´ÜÀϰñ ¼¶À¯ ÀÌÇü¼ºÁõ(Ó¤ìéÍéàéë«ì¶û¡à÷ñø), ¹æ»ç ´Ü°ñ¼¶À¯¼º ÀÌÇü¼ºÁõ.
  • multiple dysplasia (lipochondrodysplasia)
    ¹µÇü¼ºÀå¾Ö (Áö¹æ¿¬°ñÇü¼ºÀå¾Ö)
  • multiple epiphyseal dysplasia
    ¹æ»ç º´¸®´Ù¹ß¼º °ñ´ÜÀÌÇü¼ºÁõ.
  • multiple epiphyseal dysplasia
    ´Ù¹ß¼º °ñ´ÜÀÌÇü¼ºÁõ(ÒýÛ¡àõÍéÓ®ì¶û¡à÷ñø).
  • neural dysplasia (amaurotic imbecility)
    ½Å°æÇü¼ºÀå¾Ö (½Ã°¢°á¿©¼ºÄ¡¿ì)
  • oculo-auriculo-vertebral dysplasia
    ´«±ÍôÃßÇü¼ºÀå¾Ö
  • oculo-dento-digital dysplasia
    ´«-ÀÌ-¼Õ¹ß°¡¶ô ÀÌÇü¼º
  • oculo-dento-osseous dysplasia
    ´«-ÀÌ-»À ÀÌÇü¼º
  • oculoauriculovertebral dysplasia
    ¾ÈÀÌôÃßÀÌÇü¼º, ¾ÈÀÌôÃß ¹ßÀ°
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Fibrous bone marrow
    ¼¶À¯°ñ¼ö [¼¶À¯»À¼ÓÁú]
    [¿¾ ¿ë¾î] ¼¶À¯¼º°ñ¼ö
  • Reticulofibrous periosteal bone
    ¼¼¸Á¼¶À¯»À¹Ù±ù¸·»À
    [¿¾ ¿ë¾î] ¼¼¸Á¼¶À¯¼º°ñ¸·°ñ
  • Triquetral bone
    ¼¼¸ð»À
    [¿¾ ¿ë¾î] »ï°¢±Ù
  • Third metacarpal bone
    ¼Â°¼ÕÇ㸮»À
    [¿¾ ¿ë¾î] Á¦1Áß¼ö°ñ
  • Scaphoid bone
    ¼Õ¹è»À
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ
  • Tubercle of scaphoid bone
    ¼Õ¹è»À°áÀý
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ°áÀý
  • Gelatinous bone marrow
    ¾Æ±³°ñ¼ö [¾Æ±³»À¼ÓÁú]
    [¿¾ ¿ë¾î] ±³¾ç°ñ¼ö
  • Gelatinous bone marrow
    ¾Æ±³°ñ¼ö [¾Æ±³»À¼ÓÁú]
    [¿¾ ¿ë¾î] ¾Æ±³°ñ¼ö
  • Medial cuneiform bone
    ¾ÈÂʽû±â»À
    [¿¾ ¿ë¾î] ³»Ãø¼³»ó°ñ
  • Capitate bone
    ¾Ë¸Ó¸®»À
    [¿¾ ¿ë¾î] À¯µÎ°ñ
  • Perichondral bone
    ¿¬°ñ¸·»À
    [¿¾ ¿ë¾î] ¿¬°ñ¸·°ñ
  • Cartilagenous bone
    ¿¬°ñ»À
    [¿¾ ¿ë¾î] ¿¬°ñ¼º°ñ
  • Definite compact bone
    ¿Ï¼ºÄ¡¹Ð»À
    [¿¾ ¿ë¾î] ¿Ï¼ºÄ¡¹Ð°ñ
  • Frontal bone
    À̸¶»À [ÀüµÎ°ñ]
    [¿¾ ¿ë¾î] ÀüµÎ°ñ
  • Squama of frontal bone
    À̸¶»Àºñ´Ã
    [¿¾ ¿ë¾î] ÀüµÎ¸°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • marble bone disease
    ´ë¸®¼®°ñº´
  • maxillary bone
    »ó¾Ç°ñ
  • membranous bone
    ¸·°ñ
  • metacarpal bone
    Áß¼ö°ñ
  • metatarsal bone
    ÁßÁ·°ñ
  • navicular bone
    ¹ß¹è°ñ, ÁÖ»ó°ñ
  • new bone formation
    ½Å°ñÇü¼º
  • occipital bone
    逵롖
  • palatine bone
    ±¸°³°ñ
  • parietal bone
    µÎÁ¤°ñ
  • periosteal bone
    °ñ¸·(¼º)°ñ
  • periosteal new bone
    °ñ¸·¼º½Å»ý°ñ
  • pubic bone
    Ä¡°ñ
  • reactive bone excrescence
    ¹ÝÀÀ¼º°ñµ¹Ãâ
  • resorption of bone
    °ñÈí¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ABM adjusted body mass; alveolar basement membrane; autologous bone marrow
ABMI autologous bone marrow transplantation
ABMT American Board of Medical Toxicology; autologous bone marrow transplantation
AC/BC air conduction/bone conduction [time ratio]
ADR activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FCD Focal cortical dysplasia
HGD High Grade Dysplasia
HED Hypohidrotic ectodermal dysplasia
IND Intestinal Neuronal Dysplasia
LCD Liver cell dysplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • base of metacarpal bone
    ¼ÕÇ㸮»À ¹Ù´Ú
  • blade bone
    °ß°© °ñ
  • body of hyoid bone
    ¼³°ñ ü
  • body shaft of metacarpal bone
    Á¤¿Ü Áß¼ö°ñü
    µ¿ÀǾî=cor
  • bone
    °ñ, »À
    1. ´ë´Ù¼ö ôÃß µ¿¹°ÀÇ °ñ°ÝÀÇ ´ëºÎºÐÀ» ±¸¼ºÇÏ´Â °ß°íÇÑ ÇüÅÂÀÇ °áÇÕÁ¶Á÷À̸ç, À¯±â ¼ººÐ°ú ¹«±â ¼ººÐÀ¸·Î ±¸¼ºµÈ´Ù. ±âÁúÀº ±³¿øÁú ¼¶À¯ ±¸Á¶¸¦ °¡Áö¸ç ±× ¼Ó¿¡ ¹«±â ¼ººÐÀÌ Ä§ÅõµÇ¾î ÀÖ´Ù. ¹«±â ¼ººÐÀº ÁÖ·Î Àλê Ä®½·°ú ź»ê Ä®½·À¸·Î µÇ¾î ÀÖ°í, À̰͵éÀÌ °ñÀÇ °æµµ¿¡ ±â¿©Çϰí ÀÖ´Ù. 2. ÁÖ¿ä ¼ººÐÀº °ñÁú·Î °ñÁ¶Á÷À¸·Î µÇ¾îÀÖÀ¸¸ç ¿ÜÃøÀº °ñ¸·À¸·Î µ¤¿©ÀÖ°í ³»ºÎ¿¡´Â °ñ¼ö°¡ È帥´Ù. ¿ÜÇüÀ¸·Î Àå°ñ, ´Ü°ñ, ÆíÆò°ñ·Î ³ª´µ¾îÁø´Ù.
  • bone activity
    °ñ Ȱ¼º
  • bone age
    °ñ·É, °ñ ¿¬·É
    °ñ ¼º¼÷µµ¸¦ ³ªÅ¸³»´Â °³³äÀÌ°í °Ç°­¿¡¼­ ¾òÀº ÀÏÁ¤ÇÑ Ç¥ÁØÀ» ¿¬·É°úÀÇ °ü°è·Î Ç¥ÇöÇÑ °ÍÀÌ´Ù.
  • bone and joint surgery
    °ñ°üÀý ¿Ü°ú
  • bone ash
    °ñȸ
    »À¸¦ Å¿ö¼­ ¸¸µç °¡·ç, ºñ·á¿¡ ¾²À̱⵵ ÇÑ´Ù.
  • bone augmentation
    °ñ Áõ´ë¼ú
  • bone blend
    °ñ È¥ÇÕ
  • bone cell
    °ñ ¼¼Æ÷
    °ñÁ¶Á÷ÀÇ ±âº» ¼¼Æ÷. °ñ Á¶Á÷¿¡´Â µüµüÇÑ °ñ ±âÁú¾È¿¡ °ñ¼Ò°­À̶ó°í ÇÏ´Â Æ´ÀÌ ±ºµ¥±ºµ¥ ÀÖ°í, ±× ¼Ó¿¡ 1°³¾¿ÀÇ °ñ ¼¼Æ÷°¡ µé¾î ÀÖ´Ù. °ñ ¼¼Æ÷ÀÇ ÇüÅ´ °ñ¼Ò°­°ú ÀÏÄ¡ÇÏ¿© ÆíÆòÇÑ Å¸¿øÇüÀ¸·Î, ±æÀÌ´Â 15¡­27 ¥ìmÀÌ´Ù. °ñ ¼¼Æ÷´Â ´Ù¼öÀÇ °¡´Â ¿øÇüÁú µ¹±â°¡ À־, À̰ÍÀÌ ±âÁú ³»ÀÇ °ñ ¼¼°üÀ» ÅëÇÏ¿© °¡±îÀÌ ÀÖ´Â °ñ ¼¼Æ÷ÀÇ µ¹±â¿Í ÇÕÄ£´Ù. °ñ ¼¼Æ÷´Â º»·¡ °áÇÕÁ¶Á÷ÀÇ ¼¶À¯¾Æ¼¼Æ÷¿¡¼­ Çü¼ºµÇ´Â °ÍÀ¸·Î, ¸ÕÀú °ñ¾Æ¼¼Æ÷°¡ µÇ¾î, À̰ÍÀÌ ±âÁúÀ» ¸¸µé°í ÀÚ½ÅÀº ±× ±âÁú ¼Ó¿¡ µé¾î°¡ °ñ¼¼Æ÷·Î µÈ´Ù. À̰ÍÀº °ñ Á¶Á÷ÀÇ Á¦Á¶ÀÚÀ̸ç, ¼¼Æ÷ÁúÀº ¹Ì·®ÀÇ ¹ÌÅäÄܵ帮¾Æ¸¦ Æ÷ÇÔÇϰí, È£¾à¿°±â¼ºÀ» ³ªÅ¸³½´Ù.
  • bone chisel
    »À ²ø
  • bone conduction test
    °ñÀüµµ ½ÃÇè
  • bone curette
    °ñÅ¥·¿, °ñ ¼ÒÆÄ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
hyperbilirubinaemia, hereditary Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.
(12 Dec 1998)
spastic paraplegia, hereditary An insidiously progressive inherited disorder (probably autosomal dominant) characterised by distal limb weakness. Stiffness of the legs in walking due to the spasticity marks the onset of the disorder. Peripheral sensory neurons may be affected in the later stages of the disease.
(12 Dec 1998)
spherocytosis, hereditary A familial congenital haemolytic anaemia characterised by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.
(12 Dec 1998)
neoplastic syndromes, hereditary The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumour tends to occur at an earlier than average age, individuals may have more than one primary tumour, the tumours may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.
(12 Dec 1998)
nephritis, hereditary Hereditary disease characterised initially by haematuria and slowly progressing to renal insufficiency. It is sometimes associated with perceptual deafness and/or congenital ocular defects.
(12 Dec 1998)
neuropathies, hereditary motor and sensory A group of slowly progressive inherited disorders in which the predominant involvement is the peripheral motor neurons with lesser involvement of the peripheral sensory neurons. Neuronal degeneration and atrophy are characteristic of these disorders. Some of the associated characteristics are phytanic acid excess, optic atrophy, and retinitis pigmentosa.
(12 Dec 1998)
neuropathies, hereditary sensory and autonomic A group of inherited disorders in which there is selective involvement of the peripheral sensory and autonomic neurons and degeneration of fibres by axonal atrophy and degeneration. Five types of disorders have been described and classified type I through type v.
(12 Dec 1998)
oedema, hereditary angioneurotic A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema.
(12 Dec 1998)
optic atrophy, hereditary An inherited disorder in which optic atrophy is associated with muscle weakness, peroneal muscular atrophy and, in some patients, lancinating pains. In these patients the peripheral sensory neurons are probably affected.
(12 Dec 1998)
telangiectasia, hereditary haemorrhagic An autosomal dominant vascular anomaly characterised by the presence of multiple small telangiectases of the skin, mucous membranes, gastrointestinal tract, and other organs, associated with recurrent episodes of bleeding from affected sites and gross or occult melena.
(12 Dec 1998)
elliptocytosis, hereditary An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape.
(12 Dec 1998)
exostoses, multiple hereditary Hereditary disorder transmitted by an autosomal dominant gene and characterised by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.
(12 Dec 1998)
eye diseases, hereditary Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.
(12 Dec 1998)
Leber's hereditary optic atrophy Hereditary degeneration of the optic nerve and papillomacular bundle with resulting rapid loss of central vision, progressive for several weeks, then usually stationary with permanent central scotoma; age of onset is variable, most often in the third decade; more males than females are affected and transmission is cytoplasmic and strictly on the female side. Mutation on the mitochondrial chromosome involved, which presumably interacts with an X-linked mutant. This mechanism may explain the bizarre sex ratio, which differs significantly from one country to another.
(05 Mar 2000)
anhidrotic ectodermal dysplasia A hereditary condition (most often x linked) that is characterised by the abnormal development of skin, absence of sweat glands, dry eyes and abnormal development of teeth.
Symptoms include absent teeth, peg teeth, inability to sweat, thin skin and heat intolerance. Mucous membrane involvement may result in a foul-smelling nasal discharge. The inability to sweat leads to the inability to maintain normal body temperature in a warm environment. Some may exhibit fevers and will require artificial cooling.
Inheritance: mostly sex-linked (X chromosome).
Origin: Gr. Plassein = to form
(12 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á